Samsung Asset Management (New York)’s Pfizer PFE Stock Holding History

Samsung Asset Management (New York)’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$2.68M	Sell	83,371 -18,572	-18%	-$621K	2.45%	10
2016 Q2	$3.41M	Sell	101,943 -75,888	-43%	-$2.42M	2.64%	10
2016 Q1	$5M	Sell	177,831 -16,948	-9%	-$484K	2.26%	12
2015 Q4	$5.96M	Sell	194,779 -119,113	-38%	-$3.75M	2.38%	12
2015 Q3	$9.35M	Buy	313,892 +57,201	+22%	+$1.83M	3.6%	5
2015 Q2	$8.17M	Sell	256,691 -1,792	-0.7%	-$58.4K	2.75%	6
2015 Q1	$8.53M	Buy	258,483 +4,964	+2%	+$158K	2.83%	6
2014 Q4	$7.49M	Sell	253,519 -18,814	-7%	-$539K	2.51%	7
2014 Q3	$7.64M	Sell	272,333 -3,309	-1%	-$92.9K	2.41%	9
2014 Q2	$7.76M	Buy	275,642 +10,129	+4%	+$289K	2.42%	11
2014 Q1	$8.09M	Sell	265,513 -13,186	-5%	-$393K	2.85%	10
2013 Q4	$8.1M	Buy	278,699 +195,855	+236%	+$5.7M	2.68%	10
2013 Q3	$2.26M	Buy	82,844 +22,555	+37%	+$614K	2.66%	7
2013 Q2	$1.6M	Buy	+60,289	New	+$1.67M	1.86%	24

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Samsung Asset Management (New York)'s PFE Position: Q3 2016 in Review

Samsung Asset Management (New York) reduced its Pfizer (PFE) stake by 18% in Q3 2016, selling an estimated $621K and leaving 83,371 shares worth $2.68M. The position accounts for 2.45% of the portfolio, ranked #10.

Samsung Asset Management (New York) first reported a position in PFE in Q2 2013 and has held it in 14 quarters since. The position peaked at $9.35M in Q3 2015. 1,963 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

Samsung Asset Management (New York) held 83,371 shares of Pfizer worth $2.68M as of Q3 2016.
Samsung Asset Management (New York) sold 18,572 Pfizer shares in Q3 2016, an estimated $621K.
Pfizer made up 2.45% of Samsung Asset Management (New York)'s portfolio in Q3 2016, its #10 holding.
Samsung Asset Management (New York) first reported a position in Pfizer in Q2 2013 and has held it in 14 quarters since.
Samsung Asset Management (New York)'s Pfizer position peaked at $9.35M in Q3 2015.
1,963 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Samsung Asset Management (New York)'s 13F filing for Q3 2016, filed 10 Nov 2016.